Do Not Stop Steroids - Leukocytosis is Expected and Not a Reason to Discontinue Treatment
Continue the pulse steroid therapy for your autoimmune encephalitis patient despite the WBC count of 24,000 cells/µL, as this degree of leukocytosis is an expected pharmacologic effect of high-dose corticosteroids and does not indicate infection or warrant discontinuation.
Why This Leukocytosis is Expected
Corticosteroid-induced leukocytosis is a well-documented phenomenon. Research specifically examining hospitalized patients without infection shows that:
- High-dose steroids cause a mean WBC increase of 4.84 × 10⁹/L within 48 hours 1
- The peak WBC response occurs at 48 hours after steroid administration 1
- Your patient's count of 24,000 (assuming baseline ~14,000-16,000) represents an increase of approximately 8,000-10,000, which is within the expected range for pulse-dose methylprednisolone
Treatment Duration Guidelines for Autoimmune Encephalitis
According to current best practice recommendations, you should not stop steroids prematurely 2:
Acute Phase Management
- High-dose corticosteroids are first-line therapy once infection is ruled out 2
- Continue until clinical, radiological, or electrophysiological improvement is documented 2
- If no improvement after initial treatment cycle, add IVIG or plasma exchange rather than stopping steroids 2
Maintenance Phase
- After acute treatment, transition to gradual oral prednisone taper as bridging therapy 2
- Optimal corticosteroid duration is 3-12 months when combined with mycophenolate mofetil 3
- Courses beyond 12 months show no additional benefit and significantly increase adverse effects (70.8% vs 21.4-29.4% in shorter courses) 3
Critical Decision Points
Rule out infection first before attributing leukocytosis solely to steroids:
- Check for fever, new focal symptoms, or clinical deterioration
- If infection is suspected, obtain appropriate cultures and imaging
- Remember that steroids can mask some infection signs 4
Monitor for true steroid complications rather than stopping therapy:
- Hyperglycemia and HPA axis suppression 4
- Cardiac arrhythmias (only with rapid IV administration >0.5g in <10 minutes) 4
- Increased infection risk due to immunosuppression 4
Common Pitfall to Avoid
Do not confuse expected steroid-induced leukocytosis with infection. The FDA label emphasizes that dosage requirements must be individualized based on disease response, not laboratory values alone 4. Stopping steroids prematurely in autoimmune encephalitis risks:
- Disease relapse (9.1% relapse rate even with adequate treatment) 3
- Need for more aggressive second-line therapy (rituximab or cyclophosphamide) 2
- Worse neurological outcomes
When to Actually Stop or Modify Steroids
Stop steroids only if:
- Clear evidence of serious infection develops that cannot be managed concurrently
- Severe steroid-specific complications occur (cardiac arrhythmias, uncontrolled hyperglycemia)
- Patient has completed appropriate treatment course (3-12 months) with documented clinical improvement 3
Your action plan: Continue pulse steroids as planned, monitor for infection clinically (not just by WBC), and plan for gradual taper over 3-12 months based on neurological response and presence of decreased consciousness at onset 3.